Insys Therapeutics (NASDAQ:INSY) is back in the news this week, after agreeing last Friday to pay a $225 million settlement to resolve criminal investigations regarding its role in marketing opioids, an addictive painkiller. This week, we’ve seen INSY close at a record low after the opioid maker said it filed for bankruptcy after the settlement. But today, things have shifted in a new direction: INSY stock is up nearly 300%.
Here’s why.
INSY Stock Shoots Up Nearly 300%On Monday, June 10, Insys Therapeutics, a leading drug maker, filed for Chapter 11 bankruptcy protection ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.